Literature DB >> 13284343

B.C.G. AND vole bacillus vaccines in the prevention of tuberculosis in adolescents; first (progress) report to the Medical Research Council by their Tuberculosis Vaccines Clinical Trials Committee.

.   

Abstract

Entities:  

Keywords:  BCG VACCINATION; TUBERCULOSIS/immunology; VACCINES AND VACCINATION

Mesh：

Substances：

Year:  1956        PMID： 13284343      PMCID： PMC1979068     

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  A comparison of vaccination with vole bacillus and B.C.G. vaccines.

Authors:  H W FREW; J R DAVIDSON; J T REID
Journal:  Br Med J       Date:  1955-01-15

2.  The occurrence of pulmonary lesions in BCG-vaccinated and unvaccinated persons.

Authors:  S C STEIN; J D ARONSON
Journal:  Am Rev Tuberc       Date:  1953-11

3.  Tuberculin sensitivity and contact with tuberculosis; further evidence of nonspecific sensitivity.

Authors:  C E PALMER
Journal:  Am Rev Tuberc       Date:  1953-11
  3 in total
  9 in total

Review 1.  Does BCG have a role in tuberculosis control and prevention in the United Kingdom?

Authors:  S S S Teo; D V Shingadia
Journal:  Arch Dis Child       Date:  2006-06       Impact factor: 3.791

2.  Naturally attenuated, orally administered Mycobacterium microti as a tuberculosis vaccine is better than subcutaneous Mycobacterium bovis BCG.

Authors:  Yukari C Manabe; Cherise P Scott; William R Bishai
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  Progression from latent infection to active disease in dynamic tuberculosis transmission models: a systematic review of the validity of modelling assumptions.

Authors:  Nicolas A Menzies; Emory Wolf; David Connors; Meghan Bellerose; Alyssa N Sbarra; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Peter J White; Ibrahim Abubakar; Joshua A Salomon
Journal:  Lancet Infect Dis       Date:  2018-04-10       Impact factor: 25.071

4.  Surprisingly high specificity of the PPD skin test for M. tuberculosis infection from recent exposure in The Gambia.

Authors:  Philip C Hill; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; Moses D Lugos; David J Jeffries; Simon A Donkor; Richard A Adegbola; Keith P W J McAdam
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

5.  Using ELISPOT to expose false positive skin test conversion in tuberculosis contacts.

Authors:  Philip C Hill; David J Jeffries; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; Moses D Lugos; Simon A Donkor; Bouke C de Jong; Tumani Corrah; Richard A Adegbola; Keith P McAdam
Journal:  PLoS One       Date:  2007-01-31       Impact factor: 3.240

6.  Characteristics of severely malnourished under-five children immunized with Bacillus Calmette-Guérin following Expanded Programme on Immunization schedule and their outcomes during hospitalization at an urban diarrheal treatment centre, Bangladesh.

Authors:  Mst Mahmuda Ackhter; Abu Sadat Mohammad Sayeem Bin Shahid; Tahmeed Ahmed; Parag Palit; Irin Parvin; Md Zahidul Islam; Tahmina Alam; Shamsun Nahar Shaima; Lubaba Shahrin; Farzana Afroze; Monira Sarmin; Shoeb Bin Islam; Zubair Akhtar; Mohammod Jobayer Chisti; Fahmida Chowdhury
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

7.  BCG vaccination in England since 2005: a survey of policy and practice.

Authors:  Daniel Pilger; Patrick Nguipdop-Djomo; Ibrahim Abubakar; David Elliman; Laura C Rodrigues; John M Watson; Vera Eastman; Punam Mangtani
Journal:  BMJ Open       Date:  2012-09-10       Impact factor: 2.692

8.  Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection.

Authors:  Philip C Hill; Roger H Brookes; Annette Fox; Dolly Jackson-Sillah; David J Jeffries; Moses D Lugos; Simon A Donkor; Ifedayo M Adetifa; Bouke C de Jong; Alex M Aiken; Richard A Adegbola; Keith P McAdam
Journal:  PLoS Med       Date:  2007-06       Impact factor: 11.069

9.  Timing of Mycobacterium tuberculosis exposure explains variation in BCG effectiveness: a systematic review and meta-analysis.

Authors:  James M Trauer; Andrew Kawai; Anna K Coussens; Manjula Datta; Bridget M Williams; Emma S McBryde; Romain Ragonnet
Journal:  Thorax       Date:  2021-04-23       Impact factor: 9.139
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.